المؤلفون: Gomis-Bellmunt A; Catalan Institute of Vine and Wine (INCAVI). Plaça Àgora, 2, 08720 Vilafranca del Penedès, Barcelona, Spain; Laboratorio de Analisis Sensorial Euskal Herriko Unibertsitatea (LASEHU). Lactiker research group. Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Centro de investigacion Lascaray Ikergunea, Avenida Miguel de Unamuno 3, 01006 Vitoria-Gasteiz, Spain., Claret A; Food Quality and Technology, Intitute of Agrifood research and Technology (IRTA). Finca Camps i Armet, 17121 Monells, Girona, Spain., Guerrero L; Food Quality and Technology, Intitute of Agrifood research and Technology (IRTA). Finca Camps i Armet, 17121 Monells, Girona, Spain., Pérez-Elortondo FJ; Laboratorio de Analisis Sensorial Euskal Herriko Unibertsitatea (LASEHU). Lactiker research group. Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Centro de investigacion Lascaray Ikergunea, Avenida Miguel de Unamuno 3, 01006 Vitoria-Gasteiz, Spain. Electronic address: franciscojose.perez@ehu.eus.

المصدر: Food research international (Ottawa, Ont.) [Food Res Int] 2024 Jan; Vol. 176, pp. 113828. Date of Electronic Publication: 2023 Dec 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Published on behalf of the Canadian Institute of Food Science and Technology by Elsevier Applied Science Country of Publication: Canada NLM ID: 9210143 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7145 (Electronic) Linking ISSN: 09639969 NLM ISO Abbreviation: Food Res Int Subsets: MEDLINE

مواضيع طبية MeSH: Wine*/analysis, Taste ; Smell ; Olive Oil

المؤلفون: Llorente A; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain., Blasco MT; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. teresa.blasco@irbbarcelona.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. teresa.blasco@irbbarcelona.org., Espuny I; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Guiu M; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Ballaré C; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Blanco E; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain., Caballé A; Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Bellmunt A; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Salvador F; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Morales A; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Nuñez M; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Loren G; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Imbastari F; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Fidalgo M; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Endothelial Pathobiology and Microenvironment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain., Figueras-Puig C; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Gibler P; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Graupera M; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.; Endothelial Pathobiology and Microenvironment Group, Josep Carreras Leukaemia Research Institute (IJC), Badalona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain., Monteiro F; Functional Genomics Core Facility, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Riera A; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Universitat de Barcelona, Barcelona, Spain., Holen I; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK., Avgustinova A; Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Spain., Di Croce L; Centre for Genomic Regulation (CRG), Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Universitat Pompeu Fabra (UPF), Barcelona, Spain., Gomis RR; Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. roger.gomis@irbbarcelona.org.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. roger.gomis@irbbarcelona.org.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain. roger.gomis@irbbarcelona.org.; Universitat de Barcelona, Barcelona, Spain. roger.gomis@irbbarcelona.org.

المصدر: Nature cell biology [Nat Cell Biol] 2023 Dec; Vol. 25 (12), pp. 1833-1847. Date of Electronic Publication: 2023 Nov 09.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics , Breast Neoplasms*/pathology , Epigenesis, Genetic* , Estrogen Receptor alpha*/genetics , Estrogen Receptor alpha*/metabolism , Gene Amplification* , Proto-Oncogene Proteins c-maf*/genetics, Animals ; Female ; Humans ; Mice ; Cell Line, Tumor ; Chromatin ; Estrogens ; Histone Demethylases/genetics ; Histone Demethylases/metabolism

المؤلفون: Gomis-Bellmunt A; Catalan Institute of Vine and Wine (INCAVI), Plaça Àgora 2, 08720 Vilafranca del Penedès, Spain., Claret A; Food Quality and Technology, Institute of Agrifood Research and Technology (IRTA), Finca Camps i Armet, 17121 Monells, Spain., Puig-Pujol A; Catalan Institute of Vine and Wine (INCAVI), Plaça Àgora 2, 08720 Vilafranca del Penedès, Spain.; Food Quality and Technology, Institute of Agrifood Research and Technology (IRTA), Finca Camps i Armet, 17121 Monells, Spain., Pérez-Elortondo FJ; Laboratorio de Análisis Sensorial Euskal Herriko Unibertsitatea (LASEHU), Lactiker Research Group, Universidad del País Vasco/Euskal Herriko Unibertsitatea (UPV/EHU), Centro de investigación Lascaray Ikergunea, Avenida Miguel de Unamuno 3, 01006 Vitoria-Gasteiz, Spain., Guerrero L; Food Quality and Technology, Institute of Agrifood Research and Technology (IRTA), Finca Camps i Armet, 17121 Monells, Spain.

المصدر: Foods (Basel, Switzerland) [Foods] 2022 Sep 22; Vol. 11 (19). Date of Electronic Publication: 2022 Sep 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101670569 Publication Model: Electronic Cited Medium: Print ISSN: 2304-8158 (Print) Linking ISSN: 23048158 NLM ISO Abbreviation: Foods Subsets: PubMed not MEDLINE

المؤلفون: Martins-Lopes V; Departament de Ciències Fisiològiques, Institut de Neurociènces, Universitat de Barcelona, Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Catalunya, Spain., Bellmunt A; Departament de Ciències Fisiològiques, Institut de Neurociènces, Universitat de Barcelona, Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Catalunya, Spain., Greguske EA; Departament de Ciències Fisiològiques, Institut de Neurociènces, Universitat de Barcelona, Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Catalunya, Spain.; Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907, L'Hospitalet de Llobregat, Catalunya, Spain., Maroto AF; Departament de Ciències Fisiològiques, Institut de Neurociènces, Universitat de Barcelona, Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Catalunya, Spain.; Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907, L'Hospitalet de Llobregat, Catalunya, Spain., Boadas-Vaello P; Research Group of Clinical Anatomy, Embryology and Neuroscience (NEOMA), Departament de Ciències Mèdiques, Facultat de Medicina, Universitat de Girona, 17003, Girona, Catalunya, Spain., Llorens J; Departament de Ciències Fisiològiques, Institut de Neurociènces, Universitat de Barcelona, Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Catalunya, Spain. jllorens@ub.edu.; Institut d'Investigació Biomèdica de Bellvitge, IDIBELL, 08907, L'Hospitalet de Llobregat, Catalunya, Spain. jllorens@ub.edu.

المصدر: Journal of the Association for Research in Otolaryngology : JARO [J Assoc Res Otolaryngol] 2019 Dec; Vol. 20 (6), pp. 553-563. Date of Electronic Publication: 2019 Jul 11.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Springer-Verlag New York Inc Country of Publication: United States NLM ID: 100892857 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1438-7573 (Electronic) Linking ISSN: 14387573 NLM ISO Abbreviation: J Assoc Res Otolaryngol Subsets: MEDLINE

مواضيع طبية MeSH: Gravitation*, Reflex/*physiology , Vestibule, Labyrinth/*physiology, Animals ; Dose-Response Relationship, Drug ; Male ; Nitriles/toxicity ; Rats ; Rats, Long-Evans ; Vestibule, Labyrinth/drug effects ; Vestibule, Labyrinth/pathology

المؤلفون: Gawrzak S; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Rinaldi L; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Gregorio S; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Arenas EJ; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Salvador F; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Urosevic J; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; CIBERONC, Madrid, Spain., Figueras-Puig C; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Rojo F; CIBERONC, Madrid, Spain.; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain., Del Barco Barrantes I; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Cejalvo JM; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain., Palafox M; Experimental Therapeutics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain., Guiu M; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; CIBERONC, Madrid, Spain., Berenguer-Llergo A; Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Symeonidi A; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Bellmunt A; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Kalafatovic D; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Arnal-Estapé A; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Department of Pathology, Yale University School of Medicine, Yale, CT, USA., Fernández E; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Müllauer B; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Groeneveld R; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Slobodnyuk K; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Stephan-Otto Attolini C; Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Saura C; Department of Oncology, Vall d'Hebrón University Hospital, Barcelona, Spain.; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Arribas J; CIBERONC, Madrid, Spain.; Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Universitat Autònoma de Barcelona, Bellaterra, Spain.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Cortes J; Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Ramon y Cajal University Hospital, Madrid, Spain., Rovira A; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Service, Hospital del Mar, Barcelona, Spain., Muñoz M; Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain.; Department of Oncology, Hospital Clinic de Barcelona, Barcelona, Spain., Lluch A; CIBERONC, Madrid, Spain.; Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain.; University of Valencia, Valencia, Spain.; INCLIVA, Instituto de Investigación Sanitaria, Valencia, Spain., Serra V; CIBERONC, Madrid, Spain.; Experimental Therapeutics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain., Albanell J; CIBERONC, Madrid, Spain.; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Service, Hospital del Mar, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain.; Department of Oncology, Hospital Clinic de Barcelona, Barcelona, Spain., Nebreda AR; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Benitah SA; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Gomis RR; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. roger.gomis@irbbarcelona.org.; CIBERONC, Madrid, Spain. roger.gomis@irbbarcelona.org.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. roger.gomis@irbbarcelona.org.; Universitat de Barcelona, Barcelona, Spain. roger.gomis@irbbarcelona.org.

المصدر: Nature cell biology [Nat Cell Biol] 2018 Aug; Vol. 20 (8), pp. 990.

نوع المنشور: Journal Article; Published Erratum

بيانات الدورية: Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: PubMed not MEDLINE

المؤلفون: Gawrzak S; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Rinaldi L; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Gregorio S; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Arenas EJ; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Salvador F; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Urosevic J; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; CIBERONC, Madrid, Spain., Figueras-Puig C; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Rojo F; CIBERONC, Madrid, Spain.; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain., Del Barco Barrantes I; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Cejalvo JM; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain., Palafox M; Experimental Therapeutics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain., Guiu M; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; CIBERONC, Madrid, Spain., Berenguer-Llergo A; Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Symeonidi A; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Bellmunt A; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Kalafatovic D; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Arnal-Estapé A; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; Department of Pathology, Yale University School of Medicine, Yale, CT, USA., Fernández E; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Müllauer B; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Groeneveld R; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Slobodnyuk K; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Stephan-Otto Attolini C; Biostatistics and Bioinformatics Unit, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain., Saura C; Department of Oncology, Vall d'Hebrón University Hospital, Barcelona, Spain.; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Arribas J; CIBERONC, Madrid, Spain.; Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Universitat Autònoma de Barcelona, Bellaterra, Spain.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Cortes J; Vall d'Hebron Institute of Oncology, Barcelona, Spain.; Ramon y Cajal University Hospital, Madrid, Spain., Rovira A; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Service, Hospital del Mar, Barcelona, Spain., Muñoz M; Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain.; Department of Oncology, Hospital Clinic de Barcelona, Barcelona, Spain., Lluch A; CIBERONC, Madrid, Spain.; Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain.; University of Valencia, Valencia, Spain.; INCLIVA, Instituto de Investigación Sanitaria, Valencia, Spain., Serra V; CIBERONC, Madrid, Spain.; Experimental Therapeutics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain., Albanell J; CIBERONC, Madrid, Spain.; Cancer Research Program, IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.; Medical Oncology Service, Hospital del Mar, Barcelona, Spain.; Universitat Pompeu Fabra, Barcelona, Spain., Prat A; Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain.; Department of Oncology, Hospital Clinic de Barcelona, Barcelona, Spain., Nebreda AR; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Benitah SA; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain., Gomis RR; Oncology Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain. roger.gomis@irbbarcelona.org.; CIBERONC, Madrid, Spain. roger.gomis@irbbarcelona.org.; ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain. roger.gomis@irbbarcelona.org.; Universitat de Barcelona, Barcelona, Spain. roger.gomis@irbbarcelona.org.

المصدر: Nature cell biology [Nat Cell Biol] 2018 Feb; Vol. 20 (2), pp. 211-221. Date of Electronic Publication: 2018 Jan 22.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms/*genetics , GATA3 Transcription Factor/*genetics , Hepatocyte Nuclear Factor 3-alpha/*genetics , Ribosomal Protein S6 Kinases, 90-kDa/*genetics, Adult ; Aged ; Animals ; Biomarkers, Tumor/genetics ; Bone Neoplasms/genetics ; Bone Neoplasms/pathology ; Bone Neoplasms/secondary ; Breast Neoplasms/pathology ; Cell Differentiation/genetics ; Chromatin/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Genome, Human/genetics ; Humans ; Mice ; Middle Aged ; Neoplasm Metastasis ; Prognosis ; RNA, Small Interfering/genetics ; Receptors, Estrogen/genetics ; Xenograft Model Antitumor Assays

المؤلفون: Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, Fernández-Ruiz S, Morciano G, Caro-Maldonado A, Guiu M, Zúñiga-García P, Graupera M, Bellmunt A, Pandya P, Lorente M, Martín-Martín N, Sutherland JD, Sanchez-Mosquera P, Bozal-Basterra L, Zabala-Letona A, Arruabarrena-Aristorena A, Berenguer A, Embade N, Ugalde-Olano A, Lacasa-Viscasillas I, Loizaga-Iriarte A, Unda-Urzaiz M, Schultz N, Aransay AM, Sanz-Moreno V, Barrio R, Velasco G, Pinton P, Cordon-Cardo C, Locasale JW, Gomis RR, Carracedo A

المصدر: Nature cell biology [Nat Cell Biol] 2017 Jun 29; Vol. 19 (7), pp. 873.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: PubMed not MEDLINE

المؤلفون: Torrano V; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Valcarcel-Jimenez L; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Cortazar AR; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Liu X; Department of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina 27710, USA., Urosevic J; Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), The Barcelona Institute of Science and Technology, Barcelona 08028, Catalonia, Spain., Castillo-Martin M; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Pathology, Fundação Champalimaud, Lisboa, Portugal., Fernández-Ruiz S; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Morciano G; Dept. of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Italy., Caro-Maldonado A; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Guiu M; Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), The Barcelona Institute of Science and Technology, Barcelona 08028, Catalonia, Spain., Zúñiga-García P; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Graupera M; Vascular Signalling Laboratory, Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Gran Via de l'Hospitalet 199-203, 08907 L'Hospitalet de Llobregat, Barcelona, Spain., Bellmunt A; Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), The Barcelona Institute of Science and Technology, Barcelona 08028, Catalonia, Spain., Pandya P; Tumour Plasticity Team, Randall Division of Cell and Molecular Biophysics, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK., Lorente M; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University and Instituto de Investigaciones Sanitarias San Carlos (IdISSC) 28040 Madrid, Spain., Martín-Martín N; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Sutherland JD; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Sanchez-Mosquera P; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Bozal-Basterra L; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Zabala-Letona A; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Arruabarrena-Aristorena A; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Berenguer A; Biostatistics / Bioinformatics Unit, - IRB Barcelona, Parc Científic de Barcelona, 08028 Barcelona, Spain., Embade N; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Ugalde-Olano A; Department of Pathology, Basurto University Hospital, 48013 Bilbao, Spain., Lacasa-Viscasillas I; Department of Urology, Basurto University Hospital, 48013 Bilbao, Spain., Loizaga-Iriarte A; Department of Urology, Basurto University Hospital, 48013 Bilbao, Spain., Unda-Urzaiz M; Department of Urology, Basurto University Hospital, 48013 Bilbao, Spain., Schultz N; Computational Biology, Memorial Sloan-Kettering Cancer Center, NY, 10065, USA., Aransay AM; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd)., Sanz-Moreno V; Tumour Plasticity Team, Randall Division of Cell and Molecular Biophysics, King's College London, New Hunt's House, Guy's Campus, London SE1 1UL, UK., Barrio R; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain., Velasco G; Department of Biochemistry and Molecular Biology I, School of Biology, Complutense University and Instituto de Investigaciones Sanitarias San Carlos (IdISSC) 28040 Madrid, Spain., Pinton P; Dept. of Morphology, Surgery and Experimental Medicine, Section of Pathology, Oncology and Experimental Biology, University of Ferrara, Italy., Cordon-Cardo C; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Locasale JW; Department of Pharmacology and Cancer Biology, Duke Cancer Institute, Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina 27710, USA., Gomis RR; Oncology Programme, Institute for Research in Biomedicine (IRB-Barcelona), The Barcelona Institute of Science and Technology, Barcelona 08028, Catalonia, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain., Carracedo A; CIC bioGUNE, Bizkaia Technology Park, 801 bld., 48160 Derio, Bizkaia, Spain.; Ikerbasque, Basque foundation for science, 48011 Bilbao, Spain.; Biochemistry and Molecular Biology Department, University of the Basque Country (UPV/EHU), P. O. Box 644, E-48080 Bilbao, Spain.

المصدر: Nature cell biology [Nat Cell Biol] 2016 Jun; Vol. 18 (6), pp. 645-656. Date of Electronic Publication: 2016 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: MEDLINE

مواضيع طبية MeSH: Mitochondria/*metabolism , Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha/*metabolism , Prostatic Neoplasms/*metabolism, Animals ; Disease Models, Animal ; Energy Metabolism/physiology ; Heat-Shock Proteins/metabolism ; Humans ; Male ; Mice ; Neoplasm Metastasis/pathology ; Prostatic Neoplasms/pathology ; Receptors, Estrogen/metabolism ; ERRalpha Estrogen-Related Receptor

المؤلفون: Pavlovic M; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Arnal-Estapé A; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Rojo F; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Bellmunt A; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Tarragona M; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Guiu M; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Planet E; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Garcia-Albéniz X; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Morales M; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Urosevic J; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Gawrzak S; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Rovira A; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Prat A; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Nonell L; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Lluch A; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Jean-Mairet J; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Coleman R; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Albanell J; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG)., Gomis RR; Oncology Program (MP, AAE, AB, MT, MG, XGA, MM, JU, SG, RRG) and Biostatistics and Bioinformatics Unit (EP), Institute for Research in Biomedicine (IRB Barcelona), Barcelona, Spain; Cancer Research Program (FR, AR, JA) and Microarray Analysis Service (LN), IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain; Pathology Department, IIS-Fundación Jimenez Diaz, Madrid, Spain (FR); Medical Oncology Service, Hospital del Mar, Barcelona, Spain (AR, JA); Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain (AL); Valencia Central University, Spain (AL); Inbiomotion, Barcelona, Spain (JJM); Sheffield Cancer Research Centre, Sheffield, UK (RC); Universitat Pompeu Fabra, Barcelona, Spain (JA); Translational Genomics, Vall d'Hebron Insitute of Oncology, Barcelona, Spain (AP); Department of Epidemiology, Harvard School of Public Health, Boston, MA (XGA); Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain (RRG). roger.gomis@irbbarcelona.org.

المصدر: Journal of the National Cancer Institute [J Natl Cancer Inst] 2015 Sep 15; Vol. 107 (12), pp. djv256. Date of Electronic Publication: 2015 Sep 15 (Print Publication: 2015).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 7503089 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1460-2105 (Electronic) Linking ISSN: 00278874 NLM ISO Abbreviation: J Natl Cancer Inst Subsets: MEDLINE

مواضيع طبية MeSH: DNA Copy Number Variations*, Biomarkers, Tumor/*metabolism , Bone Neoplasms/*metabolism , Bone Neoplasms/*secondary , Breast Neoplasms/*metabolism , Breast Neoplasms/*pathology , Proto-Oncogene Proteins c-maf/*metabolism, Animals ; Cell Line, Tumor ; Female ; Gene Expression Regulation, Neoplastic ; Heterografts ; Humans ; Immunohistochemistry ; In Situ Hybridization, Fluorescence ; Incidence ; Mice ; Mice, Inbred BALB C ; Odds Ratio ; Predictive Value of Tests ; Prognosis ; Proportional Hazards Models ; Up-Regulation

المؤلفون: Urosevic J; 1] Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain [2]., Garcia-Albéniz X; 1] Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain [2] Institut de Malalties Hemato-Oncològiques, Hospital Clínic de Barcelona-IDIBAPS and CIBER-EHD), 08036 Barcelona, Spain [3]., Planet E; Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain., Real S; Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain., Céspedes MV; 1] Grup d'Oncogenesi i Antitumorals, Hospital de Sant Pau, 08026 Barcelona, Spain [2] Grup d'Oncogenesi i Antitumorals, Institute of Biomedical Research (IIB Sant Pau), Network Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08026 Barcelona, Spain., Guiu M; Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain., Fernandez E; Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain., Bellmunt A; Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain., Gawrzak S; Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain., Pavlovic M; Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain., Mangues R; 1] Grup d'Oncogenesi i Antitumorals, Hospital de Sant Pau, 08026 Barcelona, Spain [2] Grup d'Oncogenesi i Antitumorals, Institute of Biomedical Research (IIB Sant Pau), Network Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), 08026 Barcelona, Spain., Dolado I; 1] Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain [2] Molecular Partners AG, 8952 Schlieren, Switzerland., Barriga FM; Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain., Nadal C; Institut de Malalties Hemato-Oncològiques, Hospital Clínic de Barcelona-IDIBAPS and CIBER-EHD), 08036 Barcelona, Spain., Kemeny N; Memorial Sloan-Kettering Cancer Center, 10065 New York, USA., Batlle E; 1] Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain [2] Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain., Nebreda AR; 1] Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain [2] Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain., Gomis RR; 1] Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain [2] Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain.

المصدر: Nature cell biology [Nat Cell Biol] 2014 Jul; Vol. 16 (7), pp. 685-94. Date of Electronic Publication: 2014 Jun 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Macmillan Magazines Ltd Country of Publication: England NLM ID: 100890575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4679 (Electronic) Linking ISSN: 14657392 NLM ISO Abbreviation: Nat Cell Biol Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasm Metastasis* , Signal Transduction*, Colonic Neoplasms/*pathology , Liver Neoplasms/*secondary , Lung Neoplasms/*secondary , Parathyroid Hormone-Related Protein/*metabolism , p38 Mitogen-Activated Protein Kinases/*metabolism, Animals ; Cells, Cultured ; Colonic Neoplasms/physiopathology ; Disease Models, Animal ; Endothelial Cells/metabolism ; Humans ; Mice ; Mutation ; Parathyroid Hormone-Related Protein/genetics ; p38 Mitogen-Activated Protein Kinases/genetics ; ras Proteins/genetics ; ras Proteins/metabolism